Medical Device

Nuvectra (NASDAQ:NVTR), a neurostimulation medical device company, announced today the pricing of its underwritten follow-on public offering of 2,825,000 shares of its common stock at a price to the public of $8.00 per share. As quoted in the press release: The offering is expected to close on or about February 5, 2018, subject to customary closing …

Nuvectra (NASDAQ:NVTR), a neurostimulation medical device company, announced today the pricing of its underwritten follow-on public offering of 2,825,000 shares of its common stock at a price to the public of $8.00 per share.

As quoted in the press release:

The offering is expected to close on or about February 5, 2018, subject to customary closing conditions. In addition, Nuvectra has granted the underwriters a 30-day option to purchase up to 423,750 additional shares of common stock on the same terms and conditions.

Piper Jaffray is acting as sole book-running manager for the offering. JMP Securities and SunTrust Robinson Humphrey are acting as co-managers.

Click here to read the full press release.

MARKETS

Markets
TSX18729.66-104.50
TSXV602.35-13.59
DOW31037.68+69.86
S&P 5003845.08+13.69
NASD11361.85+39.61
ASX6629.30+16.70

COMMODITIES

Commodities
Gold1740.12-28.75
Silver19.19-0.03
Copper3.44+0.03
Palladium1923.51-4.50
Platinum857.00-8.00
Oil98.29-0.24
Heating Oil3.43+0.02
Natural Gas5.53+0.02

DOWNLOAD FREE REPORTS

×